Table 3.
Type-Specific Clearance of Human Papillomavirus Infectionsa in Men Who Have Sex With Men and Men Who Have Sex With Women in the HPV in Men (HIM) Study, 2005–2009
MSM infections |
MSW infections |
|||
Prevalent | Cleared | Prevalent | Cleared | |
No. | No. (%) | No. | No. (%) | |
Any HPV | 212 | 121 (57.1) | 175 | 124 (70.9) |
Oncogenicb | 77 | 43 (55.8) | 71 | 55 (77.5) |
16 | 11 | 3 (27.2) | 21 | 21 (100.0) |
18 | 8 | 5 (62.5) | 2 | 2 (100.0) |
51 | 10 | 6 (60.0) | 12 | 8 (66.7) |
56 | 5 | 4 (80.0) | 5 | 4 (80.0) |
59 | 5 | 4 (80.0) | 8 | 8 (100.0) |
Non-oncogenicc | 135 | 78 (57.8) | 104 | 69 (66.3) |
06 | 15 | 7 (46.7) | 19 | 15 (78.9) |
11 | 5 | 2 (40.0) | 1 | 1 (100.0) |
53 | 13 | 8 (61.5) | 8 | 5 (62.5) |
61 | 9 | 3 (33.3) | 10 | 5 (50.0) |
62 | 5 | 3 (60.0) | 14 | 8 (57.1) |
71 | 6 | 2 (33.3) | 5 | 3 (60.0) |
81 | 6 | 2 (33.3) | 5 | 2 (40.0) |
84 | 16 | 10 (62.5) | 7 | 6 (85.7) |
89d | 8 | 5 (62.5) | 11 | 8 (72.7) |
Abbreviations: HPV, human papillomavirus; MSM, men who have sex with men; MSW, men who have sex with women.
The unit of analysis for clearance was infections instead of individuals.
Oncogenic types 31, 33, 35, 39, 45, 52, 58, and 68 are not shown because there were <5 prevalent infections among both MSM and MSW.
Non-oncogenic types 26, 40, 42, 54, 55, 64, 66, 67, 69, 70, 72, 73, 82, 83, and IS39 are not shown because there were <5 prevalent infections among both MSM and MSW.
HPV-89, previously CP6108.